CorMedix Inc.(CRMD)

6.13-0.61-9.05%

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
公司概况
公司名称
CorMedix Inc.
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.cormedix.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
CorMedix Inc.是于2006年7月28日在美国特拉华州注册成立。该公司是一家生物制药公司，专注于开发和商业化用于预防和治疗危及生命的疾病和状况的治疗产品。该公司的主要重点是先导产品DefenCath在美国的商业化。该公司已在全球范围内授权开发和商业化DefenCath。DefenCath这个名称是美国食品药品监督管理局（FDA）批准的美国专有名称。
- 03-25
  年度报告
  Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
  Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
- 03-25
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 01-07
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2024-11-25
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2024-11-14
  关联方拟减持公告
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 2024-11-14
  超过5%披露
  Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
  Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
- 2024-10-30
  季度报告
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2024-10-30
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2024-08-14
  季度报告
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2024-08-14
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2024-05-20
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 2024-05-09
  季度报告
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2024-05-09
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2024-03-12
  年度报告
  Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
  Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
- 2024-03-12
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report